{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:16Z","timestamp":1786979776361,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,11,10]],"date-time":"2012-11-10T00:00:00Z","timestamp":1352505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00213-012-2894-7","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T04:48:01Z","timestamp":1352436481000},"page":"883-893","source":"Crossref","is-referenced-by-count":41,"title":["Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2\u00a0h apart"],"prefix":"10.1007","volume":"225","author":[{"given":"A. M.","family":"Peir\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. N.","family":"Roset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carb\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pujadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Torrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cam\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,10]]},"reference":[{"key":"2894_CR1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-200008000-00010","volume":"20","author":"J Cam\u00ed","year":"2000","unstructured":"Cam\u00ed J, Farr\u00e9 M, Mas M, Roset PN, Poudevida S, Mas A, San L, de la Torre R (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine (\u201cEcstasy\u201d): psychomotor performance and subjective effects. J Clin Psychopharmacol 20:455\u2013466","journal-title":"J Clin Psychopharmacol"},{"key":"2894_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(03)02173-3","volume":"476","author":"L Cleary","year":"2003","unstructured":"Cleary L, Docherty JR (2003) Actions of amphetamine derivatives and cathinone at the noradrenaline transporter. Eur J Pharmacol 476:31\u201334","journal-title":"Eur J Pharmacol"},{"key":"2894_CR3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.neuroscience.2006.06.033","volume":"142","author":"RD Crean","year":"2006","unstructured":"Crean RD, Davis SA, Von Huben SN, Lay CC, Katner SN, Taffe MA (2006) Effects of (+\/\u2212) 3,4-methylenedioxymethamphetamine, (+\/\u2212)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques. Neuroscience 142:515\u2013525","journal-title":"Neuroscience"},{"issue":"11","key":"2894_CR4","doi-asserted-by":"crossref","first-page":"e27206","DOI":"10.1371\/journal.pone.0027206","volume":"6","author":"E Cuy\u00e0s","year":"2011","unstructured":"Cuy\u00e0s E, Verdejo-Garc\u00eda A, Fagundo AB, Khymenets O, Rodr\u00edguez J, Cuenca A, de Sola LS, Langohr K, Pe\u00f1a-Casanova J, Torrens M, Mart\u00edn-Santos R, Farr\u00e9 M, de la Torre R (2011) The influence of genetic and environmental factors among MDMA users in cognitive performance. PLoS One 6(11):e27206","journal-title":"PLoS One"},{"key":"2894_CR5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.2000.tb05199.x","volume":"914","author":"R Torre De la","year":"2000","unstructured":"De la Torre R, Farr\u00e9 M, Roset P, Hern\u00e1ndez-L\u00f3pez C, Mas M, Ortu\u00f1o J et al (2000a) Pharmacology of MDMA in humans. Ann NY Acad Sci 914:225\u2013237","journal-title":"Ann NY Acad Sci"},{"key":"2894_CR6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","volume":"49","author":"R Torre De la","year":"2000","unstructured":"De la Torre R, Farr\u00e9 M, Ortuno J, Mas M, Brenneisen R, Roset PN et al (2000b) Non-linear pharmacokinetics of MDMA (\u2018ecstasy\u2019) in humans. Br J Clin Pharmacol 49:104\u2013109","journal-title":"Br J Clin Pharmacol"},{"key":"2894_CR7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00228-005-0965-y","volume":"61","author":"R Torre De la","year":"2005","unstructured":"De la Torre R, Farr\u00e9 M, Mathuna BO, Roset PN, Pizarro N, Segura M et al (2005) MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers. Eur J Clin Pharmacol 61:551\u2013554","journal-title":"Eur J Clin Pharmacol"},{"key":"2894_CR8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0269881107081545","volume":"22","author":"S Sola Llopis de","year":"2008","unstructured":"de Sola Llopis S, Miguelez-Pan M, Pe\u00f1a-Casanova J, Poudevida S, Farr\u00e9 M, Pacifici R, B\u00f6hm P, Abanades S, Verdejo Garc\u00eda A, Langohr K, Zuccaro P, de la Torre R (2008) Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. J Psychopharmacol 22:498\u2013510","journal-title":"J Psychopharmacol"},{"key":"2894_CR9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00213-004-1789-7","volume":"173","author":"M Farr\u00e9","year":"2004","unstructured":"Farr\u00e9 M, De La Torre R, Mathuna BO, Roset PN, Peir\u00f3 AM, Torrens M et al (2004) Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology (Berl) 173:364\u2013375","journal-title":"Psychopharmacology (Berl)"},{"key":"2894_CR10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.107.129056","volume":"323","author":"M Farr\u00e9","year":"2007","unstructured":"Farr\u00e9 M, Abanades S, Roset PN, Peir\u00f3 AM, Torrens M, O\u2019 Mathuna B et al (2007) Pharmacological interaction between 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and paroxetine: pharmacological effects and pharmacokinetics. J Pharmacol Exp Ther 323:954\u2013962","journal-title":"J Pharmacol Exp Ther"},{"key":"2894_CR11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00213-005-0149-6","volume":"183","author":"R Freedman","year":"2005","unstructured":"Freedman R, Johanson C, Tancer M (2005) Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 183:248\u2013256","journal-title":"Psychopharmacology (Berl)"},{"key":"2894_CR12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00213-003-1725-2","volume":"173","author":"AR Green","year":"2004","unstructured":"Green AR, Sanchez V, O'Shea E, Saadat KS, Elliott JM, Colado MI (2004a) Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated (\\'binge\\' ingestion) low dose of MDMA. Psychopharmacology (Berl) 173:264\u2013269","journal-title":"Psychopharmacology (Berl)"},{"key":"2894_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejphar.2004.07.006","volume":"500","author":"AR Green","year":"2004","unstructured":"Green AR, O'Shea E, Colado MI (2004b) A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500:3\u201313","journal-title":"Eur J Pharmacol"},{"key":"2894_CR14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/ajem.2003.50028","volume":"21","author":"S Greene","year":"2003","unstructured":"Greene S, Dargan P, O'connor N, Jones AL, Kerins M (2003) Multiple toxicity from 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d). Am J Emerg Med 21:121\u2013124","journal-title":"Am J Emerg Med"},{"key":"2894_CR15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/bjc\/39.4.625","volume":"39","author":"R Hammersley","year":"1999","unstructured":"Hammersley R, Ditton J, Smith I, Short E (1999) Patterns of ecstasy use by drug users. Br J Criminol 39:625\u2013647","journal-title":"Br J Criminol"},{"key":"2894_CR16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.300.1.236","volume":"300","author":"C Hern\u00e1ndez-L\u00f3pez","year":"2002","unstructured":"Hern\u00e1ndez-L\u00f3pez C, Farr\u00e9 M, Roset PN, Menoyo E, Pizarro N, Ortu\u00f1o J et al (2002) 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300:236\u2013244","journal-title":"J Pharmacol Exp Ther"},{"key":"2894_CR17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.2011.78","volume":"90","author":"CM Hysek","year":"2011","unstructured":"Hysek CM, Simmler LD, Ineichen M, Grouzmann E, Hoener MC, Brenneisen R et al (2011) The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (\u201cecstasy\u201d) in humans. Clin Pharmacol Ther 90:246\u2013255","journal-title":"Clin Pharmacol Ther"},{"key":"2894_CR18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1124\/jpet.111.188425","volume":"340","author":"CM Hysek","year":"2012","unstructured":"Hysek CM, Brugger R, Simmler LD, Bruggisser M, Donzelli M, Grouzmann E et al (2012) Effects of the \u03b12-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers. J Pharmacol Exp Ther 340:286\u2013294","journal-title":"J Pharmacol Exp Ther"},{"key":"2894_CR19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0006-3223(01)01288-4","volume":"51","author":"SH Kollins","year":"2002","unstructured":"Kollins SH, Rush CR (2002) Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans. Biol Psychiatry 51:143\u2013150","journal-title":"Biol Psychiatry"},{"key":"2894_CR20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-006-0679-6","volume":"192","author":"KP Kuypers","year":"2007","unstructured":"Kuypers KP, Wingen M, Samyn N, Limbert N, Ramaekers JG (2007) Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. Psychopharmacology (Berl) 192:111\u2013119","journal-title":"Psychopharmacology (Berl)"},{"key":"2894_CR21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0376-8716(94)90075-2","volume":"35","author":"X Lamas","year":"1994","unstructured":"Lamas X, Farr\u00e9 M, Llorente M, Cam\u00ed J (1994) Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI). Drug Alcohol Depend 35:203\u2013209","journal-title":"Drug Alcohol Depend"},{"key":"2894_CR22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-133-12-200012190-00012","volume":"133","author":"SJ Lester","year":"2000","unstructured":"Lester SJ, Baggott M, Welm S, Schiller N, Jones RT, Foster E et al (2000) Cardiovascular effects of 3,4-methylenedioxymethamphetamine. Ann Intern Med 133:969\u2013973","journal-title":"Ann Intern Med"},{"key":"2894_CR23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","volume":"22","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Baumann C, Gamma A, Vollenweider FX (2000a) Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22:513\u2013521","journal-title":"Neuropsychopharmacology"},{"key":"2894_CR24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0893-133X(00)00126-3","volume":"23","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Saur MR, Gamma A, Hell D, Vollenweider FX (2000b) Psychological and physiological effects of MDMA (\u201cEcstasy\u201d) after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans. Neuropsychopharmacology 23:396\u2013404","journal-title":"Neuropsychopharmacology"},{"key":"2894_CR25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0893-133X(00)00199-8","volume":"24","author":"M Liechti","year":"2001","unstructured":"Liechti M, Geyer M, Hell D, Vollenweider F (2001) Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology 24:240\u2013252","journal-title":"Neuropsychopharmacology"},{"key":"2894_CR26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/026988110001400313","volume":"14","author":"ME Liecthi","year":"2000","unstructured":"Liecthi ME, Vollenweider FX (2000) The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4 methylenedioxymethamphetamine (\u201cEcstasy\u201d) in healthy volunteers. J Psychopharmacol 14:269\u2013274","journal-title":"J Psychopharmacol"},{"key":"2894_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1369-1600.2009.00180.x","volume":"15","author":"R Mart\u00edn-Santos","year":"2010","unstructured":"Mart\u00edn-Santos R, Torrens M, Poudevida S, Langohr K, Cuy\u00e1s E, Pacifici R, Farr\u00e9 M, Pichini S, de la Torre R (2010) 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study. Addict Biol 15:15\u201322","journal-title":"Addict Biol"},{"key":"2894_CR28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","volume":"290","author":"M Mas","year":"1999","unstructured":"Mas M, Farr\u00e9 M, la Torre R, Roset PN, Ortu\u00f1o J, Segura J et al (1999) Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 290:136\u2013145","journal-title":"J Pharmacol Exp Ther"},{"key":"2894_CR29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00109-004-0591-7","volume":"82","author":"E Mills","year":"2004","unstructured":"Mills E, Rusyniak D, Sprague J (2004) The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine. J Mol Med 82:787\u2013799","journal-title":"J Mol Med"},{"key":"2894_CR30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1360-0443.2011.03399.x","volume":"106","author":"KM Morefield","year":"2011","unstructured":"Morefield KM, Keane M, Felgate P, White JM, Irvine RJ (2011) Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational \u2018ecstasy\u2019 users. Addiction 106:1293\u20131300","journal-title":"Addiction"},{"key":"2894_CR31","first-page":"507","volume":"52","author":"B O'Connor","year":"1994","unstructured":"O'Connor B (1994) Hazards associated with the recreational drug \u201cecstasy\u201d. Br J Hosp Med 52:507\u2013514","journal-title":"Br J Hosp Med"},{"key":"2894_CR32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0028-3908(98)00029-X","volume":"37","author":"E O'Shea","year":"1998","unstructured":"O'Shea E, Granados R, Esteban B, Colado MI, Green AR (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (\u2018ecstasy\u2019). Neuropharmacology 37:919\u2013926","journal-title":"Neuropharmacology"},{"key":"2894_CR33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0269881105048900","volume":"19","author":"A Parrott","year":"2005","unstructured":"Parrott A (2005) Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy. J Psychopharmacology 19:71\u201383","journal-title":"J Psychopharmacology"},{"key":"2894_CR34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jat\/26.3.157","volume":"26","author":"N Pizarro","year":"2002","unstructured":"Pizarro N, Ortu\u00f1o J, Farr\u00e9 M, Hern\u00e1ndez-L\u00f3pez C, Pujadas M, Llebaria A et al (2002) Determination of MDMA and its metabolites in blood and urine by gas chromatography\u2013mass spectrometry and analysis of enantiomers by capillary electrophoresis. J Anal Toxicol 26:157\u2013165","journal-title":"J Anal Toxicol"},{"key":"2894_CR35","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1360-0443.2001.967103513.x","volume":"96","author":"S Riley","year":"2001","unstructured":"Riley S, James C, Gregory D, Dingle H, Cadger M (2001) Patterns of recreational drug use at dance events in Edinburgh, Scotland. Addiction 96:1035\u20131047","journal-title":"Addiction"},{"key":"2894_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(01)00146-6","volume":"65","author":"ME Tancer","year":"2001","unstructured":"Tancer ME, Johanson CE (2001) The subjective effects of MDMA and mCPP in moderate MDMA users. Drug Alcohol Depend 65:97\u2013101","journal-title":"Drug Alcohol Depend"},{"key":"2894_CR37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hup.529","volume":"18","author":"S Verheyden","year":"2003","unstructured":"Verheyden S, Henry J, Curran H (2003) Acute, sub-acute and long-term subjective consequences of \u2018ecstasy\u2019 (MDMA) consumption in 430 regular users. Hum Psychopharmacol 18:507\u2013517","journal-title":"Hum Psychopharmacol"},{"key":"2894_CR38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.npp.1301078","volume":"32","author":"SN Huben Von","year":"2007","unstructured":"Von Huben SN, Lay CC, Crean RD, Davis SA, Katner SN, Taffe MA (2007) Impact of ambient temperature on hyperthermia induced by (+\/\u2212)3,4-methylenedioxymethamphetamine in rhesus macaques. Neuropsychopharmacology 32:673\u2013681","journal-title":"Neuropsychopharmacology"},{"key":"2894_CR39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s002130000439","volume":"150","author":"SL Walsh","year":"2000","unstructured":"Walsh SL, Haberny KA, Bigelow GE (2000) Modulation of intravenous cocaine effects by chronic oral cocaine in humans. Psychopharmacology 150:361\u2013373","journal-title":"Psychopharmacology"},{"key":"2894_CR40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1177\/0269881106065907","volume":"20","author":"J Yang","year":"2006","unstructured":"Yang J, Jamei M, Heydari A, de la Torre M, Farr\u00e9 M, Tucker GT, Rostami-Hodjegan A (2006) Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA. J Psychopharmacol 20:842\u2013849","journal-title":"J Psychopharmacol"},{"key":"2894_CR41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/11584550-000000000-00000","volume":"50","author":"S Yubero-Lahoz","year":"2011","unstructured":"Yubero-Lahoz S, Pardo R, Farr\u00e9 M, O'Mahony B, Torrens M, Mustata C, P\u00e9rez-Ma\u00f1\u00e1 C, Carb\u00f3 ML, de la Torre R (2011) Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans. Clin Pharmacokinet 50:319\u2013329","journal-title":"Clin Pharmacokinet"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2894-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-012-2894-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-012-2894-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T11:18:50Z","timestamp":1745147930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-012-2894-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2894"],"URL":"https:\/\/doi.org\/10.1007\/s00213-012-2894-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717964792.793467816","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,10]]}}}